Author:
Paleari Laura,Gandini Sara,Provinciali Nicoletta,Puntoni Matteo,Colombo Nicoletta,DeCensi Andrea
Funder
Italian Association for Cancer Research
Subject
Obstetrics and Gynaecology,Oncology
Reference68 articles.
1. SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, Based on November 2013 SEER Data Submission, Posted to the SEER Web Site;Howlader,2014
2. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study;De Angelis;Lancet Oncol.,2014
3. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N. Engl. J. Med.,2011
4. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial;Oza;Lancet Oncol.,2015
5. The cost-effectiveness of bevacizumab in advanced ovarian cancer using evidence from the ICON7 trial;Hinde;Value Health,2016
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献